{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:34:14Z","timestamp":1792078454871,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DP1 CA174422"],"award-info":[{"award-number":["DP1 CA174422"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35 CA197699"],"award-info":[{"award-number":["R35 CA197699"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intratumoral heterogeneity is a common feature of many myeloid leukemias and a significant reason for treatment failure and relapse. Thus, identifying the cells responsible for residual disease and leukemia re-growth is critical to better understanding how they are regulated. Here, we show that a knock-in reporter mouse for the stem cell gene Musashi 2 (Msi2) allows identification of leukemia stem cells in aggressive myeloid malignancies, and provides a strategy for defining their core dependencies. Specifically, we carry out a high throughput screen using Msi2-reporter blast crisis chronic myeloid leukemia (bcCML) and identify several adhesion molecules that are preferentially expressed in therapy resistant bcCML cells and play a key role in bcCML. In particular, we focus on syndecan-1, whose deletion triggers defects in bcCML growth and propagation and markedly improves survival of transplanted mice. Further, live imaging reveals that the spatiotemporal dynamics of leukemia cells are critically dependent on syndecan signaling, as loss of this signal impairs their localization, migration and dissemination to distant sites. Finally, at a molecular level, syndecan loss directly impairs integrin <jats:italic>\u03b2<\/jats:italic><jats:sub>7<\/jats:sub> function, suggesting that syndecan exerts its influence, at least in part, by coordinating integrin activity in bcCML. These data present a platform for delineating the biological underpinnings of leukemia stem cell function, and highlight the Sdc1-Itg\u03b27 signaling axis as a key regulatory control point for bcCML growth and dissemination.<\/jats:p>","DOI":"10.1038\/s41467-020-19782-x","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T11:08:08Z","timestamp":1606388888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia"],"prefix":"10.1038","volume":"11","author":[{"given":"Kyle","family":"Spinler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-6056","authenticated-orcid":false,"given":"Jeevisha","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-0412","authenticated-orcid":false,"given":"Takahiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Zimdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire S.","family":"Koechlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Lytle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1663-5118","authenticated-orcid":false,"given":"Hyog Young","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdous","family":"Anower-E-Khuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4790-8847","authenticated-orcid":false,"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Blevins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joi","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcie","family":"Kritzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7433-9750","authenticated-orcid":false,"given":"Jan","family":"Karlseder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5685-5417","authenticated-orcid":false,"given":"Mark H.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyong Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-1834","authenticated-orcid":false,"given":"Jeffrey D.","family":"Esko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5956-8536","authenticated-orcid":false,"given":"Tannishtha","family":"Reya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"19782_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.gde.2005.11.002","volume":"16","author":"T O\u2019Hare","year":"2006","unstructured":"O\u2019Hare, T., Corbin, A. S. & Druker, B. J. Targeted CML therapy: controlling drug resistance, seeking cure. Curr. Opin. Genet. Dev. 16, 92\u201399 (2006).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"19782_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ccr.2009.06.007","volume":"16","author":"KI Oravecz-Wilson","year":"2009","unstructured":"Oravecz-Wilson, K. I. et al. Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. Cancer Cell 16, 137\u2013148 (2009).","journal-title":"Cancer Cell"},{"key":"19782_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/jnci\/djn123","volume":"100","author":"X Li","year":"2008","unstructured":"Li, X. et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl Cancer Inst. 100, 672\u2013679 (2008).","journal-title":"J. Natl Cancer Inst."},{"key":"19782_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756\u2013760 (2006).","journal-title":"Nature"},{"key":"19782_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn, M. et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780\u2013783 (2009).","journal-title":"Nature"},{"key":"19782_CR6","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","volume":"94","author":"T Holyoake","year":"1999","unstructured":"Holyoake, T., Jiang, X., Eaves, C. & Eaves, A. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94, 2056\u20132064 (1999).","journal-title":"Blood"},{"key":"19782_CR7","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1182\/blood-2004-03-1114","volume":"105","author":"S Chu","year":"2005","unstructured":"Chu, S. et al. Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment. Blood 105, 2093\u20132098 (2005).","journal-title":"Blood"},{"key":"19782_CR8","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/jnci\/djk150","volume":"99","author":"X Jiang","year":"2007","unstructured":"Jiang, X., Saw, K. M., Eaves, A. & Eaves, C. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells. J. Natl Cancer Inst. 99, 680\u2013693 (2007).","journal-title":"J. Natl Cancer Inst."},{"key":"19782_CR9","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1182\/blood-2007-05-092056","volume":"111","author":"H Konig","year":"2008","unstructured":"Konig, H., Holyoake, T. L. & Bhatia, R. Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src\/Abl kinase inhibitor SKI-606. Blood 111, 2329\u20132338 (2008).","journal-title":"Blood"},{"key":"19782_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin, A. S. et al. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J. Clin. Invest 121, 396\u2013409 (2011).","journal-title":"J. Clin. Invest"},{"key":"19782_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730\u2013737 (1997).","journal-title":"Nat. Med."},{"key":"19782_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645\u2013648 (1994).","journal-title":"Nature"},{"key":"19782_CR13","first-page":"4403","volume":"60","author":"RT Costello","year":"2000","unstructured":"Costello, R. T. et al. Human acute myeloid leukemia CD34+\/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res. 60, 4403\u20134411 (2000).","journal-title":"Cancer Res."},{"key":"19782_CR14","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983\u20133988 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19782_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111\u2013115 (2007).","journal-title":"Nature"},{"key":"19782_CR16","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra061808","volume":"355","author":"CT Jordan","year":"2006","unstructured":"Jordan, C. T., Guzman, M. L. & Noble, M. Cancer stem cells. N. Engl. J. Med. 355, 1253\u20131261 (2006).","journal-title":"N. Engl. J. Med."},{"key":"19782_CR17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.stem.2014.01.009","volume":"14","author":"M Todaro","year":"2014","unstructured":"Todaro, M. et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell 14, 342\u2013356 (2014).","journal-title":"Cell Stem Cell"},{"key":"19782_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-cellbio-100814-125446","volume":"31","author":"RG Fox","year":"2015","unstructured":"Fox, R. G., Park, F. D., Koechlein, C. S., Kritzik, M. & Reya, T. Musashi signaling in stem cells and cancer. Annu. Rev. Cell Dev. Biol. 31, 249\u2013267 (2015).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"19782_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12169","volume":"7","author":"CS Koechlein","year":"2016","unstructured":"Koechlein, C. S. et al. High-resolution imaging and computational analysis of haematopoietic cell dynamics in vivo. Nat. Commun. 7, 12169 (2016).","journal-title":"Nat. Commun."},{"key":"19782_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature17988","volume":"534","author":"RG Fox","year":"2016","unstructured":"Fox, R. G. et al. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Nature 534, 407\u2013411 (2016).","journal-title":"Nature"},{"key":"19782_CR21","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1073\/pnas.102583199","volume":"99","author":"AB Dash","year":"2002","unstructured":"Dash, A. B. et al. A murine model of CML blast crisis induced by cooperation between BCR\/ABL and NUP98\/HOXA9. Proc. Natl Acad. Sci. USA 99, 7622\u20137627 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19782_CR22","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2007-02-073031","volume":"110","author":"SJ Neering","year":"2007","unstructured":"Neering, S. J. et al. Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood 110, 2578\u20132585 (2007).","journal-title":"Blood"},{"key":"19782_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert, K. et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17, 1086\u20131093 (2011).","journal-title":"Nat. Med."},{"key":"19782_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccr.2006.08.020","volume":"10","author":"TC Somervaille","year":"2006","unstructured":"Somervaille, T. C. & Cleary, M. L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10, 257\u2013268 (2006).","journal-title":"Cancer Cell"},{"key":"19782_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJMoa011573","volume":"346","author":"H Kantarjian","year":"2002","unstructured":"Kantarjian, H. et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N. Engl. J. Med. 346, 645\u2013652 (2002).","journal-title":"N. Engl. J. Med."},{"key":"19782_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","volume":"2","author":"NP Shah","year":"2002","unstructured":"Shah, N. P. et al. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell 2, 117\u2013125 (2002).","journal-title":"Cancer Cell"},{"key":"19782_CR27","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2217\/nnm-2016-0007","volume":"11","author":"PR Nair","year":"2016","unstructured":"Nair, P. R. et al. Filomicelles from aromatic diblock copolymers increase paclitaxel-induced tumor cell death and aneuploidy compared with aliphatic copolymers. Nanomedicine11, 1551\u20131569 (2016).","journal-title":"Nanomedicine"},{"key":"19782_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1046\/j.1365-2141.1997.2673084.x","volume":"98","author":"HG Drexler","year":"1997","unstructured":"Drexler, H. G., Zaborski, M. & Quentmeier, H. Interferon-gamma induced proliferation of human myeloid leukaemia cell lines. Br. J. Haematol. 98, 699\u2013710 (1997).","journal-title":"Br. J. Haematol."},{"key":"19782_CR29","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1182\/blood-2008-09-179697","volume":"114","author":"S Mumprecht","year":"2009","unstructured":"Mumprecht, S., Schurch, C., Schwaller, J., Solenthaler, M. & Ochsenbein, A. F. Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. Blood 114, 1528\u20131536 (2009).","journal-title":"Blood"},{"key":"19782_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/wound.2014.0555","volume":"4","author":"MA Stepp","year":"2015","unstructured":"Stepp, M. A., Pal-Ghosh, S., Tadvalkar, G. & Pajoohesh-Ganji, A. Syndecan-1 and ITs Expanding List of Contacts. Adv. Wound Care 4, 235\u2013249 (2015).","journal-title":"Adv. Wound Care"},{"key":"19782_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","volume":"83","author":"D Xu","year":"2014","unstructured":"Xu, D. & Esko, J. D. Demystifying heparan sulfate-protein interactions. Annu Rev. Biochem 83, 129\u2013157 (2014).","journal-title":"Annu Rev. Biochem"},{"key":"19782_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1078\/0065-1281-00706","volume":"105","author":"A Seftalioglu","year":"2003","unstructured":"Seftalioglu, A. & Karakus, S. Syndecan-1\/CD138 expression in normal myeloid, acute lymphoblastic and myeloblastic leukemia cells. Acta Histochem. 105, 213\u2013221 (2003).","journal-title":"Acta Histochem."},{"key":"19782_CR33","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1242\/jcs.00128","volume":"115","author":"MA Stepp","year":"2002","unstructured":"Stepp, M. A. et al. Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J. Cell Sci. 115, 4517\u20134531 (2002).","journal-title":"J. Cell Sci."},{"key":"19782_CR34","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1242\/jcs.067645","volume":"123","author":"DM Beauvais","year":"2010","unstructured":"Beauvais, D. M. & Rapraeger, A. C. Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation. J. Cell Sci. 123, 3796\u20133807 (2010).","journal-title":"J. Cell Sci."},{"key":"19782_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1084\/jem.20081278","volume":"206","author":"DM Beauvais","year":"2009","unstructured":"Beauvais, D. M., Ell, B. J., McWhorter, A. R. & Rapraeger, A. C. Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J. Exp. Med. 206, 691\u2013705 (2009).","journal-title":"J. Exp. Med."},{"key":"19782_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep02827","volume":"3","author":"B Chen","year":"2013","unstructured":"Chen, B., Kumar, G., Co, C. C. & Ho, C. C. Geometric control of cell migration. Sci. Rep. 3, 2827 (2013).","journal-title":"Sci. Rep."},{"key":"19782_CR37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s43018-020-0054-2","volume":"1","author":"J Bajaj","year":"2020","unstructured":"Bajaj, J. et al. An in vivo genome-wide CRISPR screen identifies the RNA-binidng protein Staufen2 as a key regulator of myeloid leukemia. Nat. Cancer 1, 410\u2013422 (2020).","journal-title":"Nat. Cancer"},{"key":"19782_CR38","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522\u2013526 (2012).","journal-title":"Nature"},{"key":"19782_CR39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature13305","volume":"511","author":"S Boumahdi","year":"2014","unstructured":"Boumahdi, S. et al. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 511, 246\u2013250 (2014).","journal-title":"Nature"},{"key":"19782_CR40","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1038\/s41375-019-0386-z","volume":"33","author":"M Yassin","year":"2019","unstructured":"Yassin, M. et al. A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivity. Leukemia 33, 2061\u20132077 (2019).","journal-title":"Leukemia"},{"key":"19782_CR41","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1158\/1078-0432.CCR-16-2728","volume":"23","author":"AE Kudinov","year":"2017","unstructured":"Kudinov, A. E., Karanicolas, J., Golemis, E. A. & Boumber, Y. Musashi RNA-binding proteins as cancer drivers and novel therapeutic targets. Clin. Cancer Res. 23, 2143\u20132153 (2017).","journal-title":"Clin. Cancer Res."},{"key":"19782_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1641","volume":"9","author":"M Gotte","year":"2007","unstructured":"Gotte, M., Kersting, C., Radke, I., Kiesel, L. & Wulfing, P. An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ. Breast Cancer Res. 9, R8 (2007).","journal-title":"Breast Cancer Res."},{"key":"19782_CR43","doi-asserted-by":"publisher","first-page":"e85737","DOI":"10.1371\/journal.pone.0085737","volume":"8","author":"SA Ibrahim","year":"2013","unstructured":"Ibrahim, S. A. et al. Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling. PLoS ONE 8, e85737 (2013).","journal-title":"PLoS ONE"},{"key":"19782_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.5","volume":"5","author":"O Jung","year":"2016","unstructured":"Jung, O. et al. Heparanase-induced shedding of syndecan-1\/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins. Oncogenesis 5, e202 (2016).","journal-title":"Oncogenesis"},{"key":"19782_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13045-016-0380-0","volume":"10","author":"K Schonfeld","year":"2017","unstructured":"Schonfeld, K. et al. Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies. J. Hematol. Oncol. 10, 13 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"19782_CR46","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1309\/74R4TB90BUWH27JX","volume":"121","author":"P Lin","year":"2004","unstructured":"Lin, P., Owens, R., Tricot, G. & Wilson, C. S. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am. J. Clin. Pathol. 121, 482\u2013488 (2004).","journal-title":"Am. J. Clin. Pathol."},{"key":"19782_CR47","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1182\/blood-2003-06-1891","volume":"103","author":"A Spiegel","year":"2004","unstructured":"Spiegel, A. et al. Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling. Blood 103, 2900\u20132907 (2004).","journal-title":"Blood"},{"key":"19782_CR48","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0301-472X(01)00741-X","volume":"29","author":"W Shen","year":"2001","unstructured":"Shen, W., Bendall, L. J., Gottlieb, D. J. & Bradstock, K. F. The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow. Exp. Hematol. 29, 1439\u20131447 (2001).","journal-title":"Exp. Hematol."},{"key":"19782_CR49","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nm1483","volume":"12","author":"L Jin","year":"2006","unstructured":"Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F. & Dick, J. E. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12, 1167\u20131174 (2006).","journal-title":"Nat. Med."},{"key":"19782_CR50","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nm1489","volume":"12","author":"DS Krause","year":"2006","unstructured":"Krause, D. S., Lazarides, K., von Andrian, U. H. & Van Etten, R. A. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat. Med. 12, 1175\u20131180 (2006).","journal-title":"Nat. Med."},{"key":"19782_CR51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.biocel.2006.10.014","volume":"39","author":"AN Alexopoulou","year":"2007","unstructured":"Alexopoulou, A. N., Multhaupt, H. A. & Couchman, J. R. Syndecans in wound healing, inflammation and vascular biology. Int J. Biochem Cell Biol. 39, 505\u2013528 (2007).","journal-title":"Int J. Biochem Cell Biol."},{"key":"19782_CR52","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1146\/annurev.biochem.68.1.729","volume":"68","author":"M Bernfield","year":"1999","unstructured":"Bernfield, M. et al. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729\u2013777 (1999).","journal-title":"Annu. Rev. Biochem."},{"key":"19782_CR53","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1172\/JCI12802","volume":"107","author":"A Woods","year":"2001","unstructured":"Woods, A. Syndecans: transmembrane modulators of adhesion and matrix assembly. J. Clin. Invest. 107, 935\u2013941 (2001).","journal-title":"J. Clin. Invest."},{"key":"19782_CR54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1083\/jcb.200404171","volume":"167","author":"DM Beauvais","year":"2004","unstructured":"Beauvais, D. M., Burbach, B. J. & Rapraeger, A. C. The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J. Cell Biol. 167, 171\u2013181 (2004).","journal-title":"J. Cell Biol."},{"key":"19782_CR55","doi-asserted-by":"publisher","first-page":"24264","DOI":"10.1074\/jbc.M113.455006","volume":"288","author":"Y Matsumoto","year":"2013","unstructured":"Matsumoto, Y. et al. Trimeric Tn antigen on syndecan 1 produced by ppGalNAc-T13 enhances cancer metastasis via a complex formation with integrin alpha5beta1 and matrix metalloproteinase 9. J. Biol. Chem. 288, 24264\u201324276 (2013).","journal-title":"J. Biol. Chem."},{"key":"19782_CR56","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1073\/pnas.1324297111","volume":"111","author":"MR Corces-Zimmerman","year":"2014","unstructured":"Corces-Zimmerman, M. R., Hong, W. J., Weissman, I. L., Medeiros, B. C. & Majeti, R. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc. Natl Acad. Sci. USA 111, 2548\u20132553 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19782_CR57","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1182\/blood-2013-06-511527","volume":"123","author":"R Jacamo","year":"2014","unstructured":"Jacamo, R. et al. Reciprocal leukemia-stroma VCAM-1\/VLA-4-dependent activation of NF-kappaB mediates chemoresistance. Blood 123, 2691\u20132702 (2014).","journal-title":"Blood"},{"key":"19782_CR58","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm909","volume":"9","author":"T Matsunaga","year":"2003","unstructured":"Matsunaga, T. et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat. Med. 9, 1158\u20131165 (2003).","journal-title":"Nat. Med."},{"key":"19782_CR59","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ccell.2016.10.003","volume":"30","author":"J Bajaj","year":"2016","unstructured":"Bajaj, J. et al. CD98-mediated adhesive signaling enables the establishment and propagation of acute myelogenous leukemia. Cancer Cell 30, 792\u2013805 (2016).","journal-title":"Cancer Cell"},{"key":"19782_CR60","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1128\/MCB.21.12.3888-3900.2001","volume":"21","author":"T Imai","year":"2001","unstructured":"Imai, T. et al. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol. Cell Biol. 21, 3888\u20133900 (2001).","journal-title":"Mol. Cell Biol."},{"key":"19782_CR61","doi-asserted-by":"publisher","first-page":"35530","DOI":"10.1074\/jbc.M114.597112","volume":"289","author":"NR Zearfoss","year":"2014","unstructured":"Zearfoss, N. R. et al. A conserved three-nucleotide core motif defines Musashi RNA binding specificity. J. Biol. Chem. 289, 35530\u201335541 (2014).","journal-title":"J. Biol. Chem."},{"key":"19782_CR62","doi-asserted-by":"publisher","first-page":"12532","DOI":"10.1074\/jbc.271.21.12532","volume":"271","author":"T Vihinen","year":"1996","unstructured":"Vihinen, T., Maatta, A., Jaakkola, P., Auvinen, P. & Jalkanen, M. Functional characterization of mouse syndecan-1 promoter. J. Biol. Chem. 271, 12532\u201312541 (1996).","journal-title":"J. Biol. Chem."},{"key":"19782_CR63","doi-asserted-by":"publisher","first-page":"30318","DOI":"10.1074\/jbc.M114.586438","volume":"289","author":"H Wang","year":"2014","unstructured":"Wang, H., Jin, H., Beauvais, D. M. & Rapraeger, A. C. Cytoplasmic domain interactions of syndecan-1 and syndecan-4 with alpha6beta4 integrin mediate human epidermal growth factor receptor (HER1 and HER2)-dependent motility and survival. J. Biol. Chem. 289, 30318\u201330332 (2014).","journal-title":"J. Biol. Chem."},{"key":"19782_CR64","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/nm.4431","volume":"23","author":"N Hosen","year":"2017","unstructured":"Hosen, N. et al. The activated conformation of integrin beta7 is a novel multiple myeloma-specific target for CAR T cell therapy. Nat. Med. 23, 1436\u20131443 (2017).","journal-title":"Nat. Med."},{"key":"19782_CR65","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.stem.2015.06.006","volume":"17","author":"HY Kwon","year":"2015","unstructured":"Kwon, H. Y. et al. Tetraspanin 3 is required for the development and propagation of acute myelogenous leukemia. Cell Stem Cell 17, 152\u2013164 (2015).","journal-title":"Cell Stem Cell"},{"key":"19782_CR66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.2889","volume":"46","author":"B Zimdahl","year":"2014","unstructured":"Zimdahl, B. et al. Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia. Nat. Genet. 46, 245\u2013252 (2014).","journal-title":"Nat. Genet."},{"key":"19782_CR67","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1084\/jem.191.2.253","volume":"191","author":"J Domen","year":"2000","unstructured":"Domen, J., Cheshier, S. H. & Weissman, I. L. The role of apoptosis in the regulation of hematopoietic stem cells: overexpression of Bcl-2 increases both their number and repopulation potential. J. Exp. Med. 191, 253\u2013264 (2000).","journal-title":"J. Exp. Med."},{"key":"19782_CR68","doi-asserted-by":"crossref","unstructured":"Bray, N. L. et al. Near-optimal probabilistic RNA-seq quantification. Nature Biotechnology 34,\u00a0525\u2013527\u00a0(2016).","DOI":"10.1038\/nbt.3519"},{"key":"19782_CR69","doi-asserted-by":"crossref","unstructured":"Pimentel, H. et al. Differential analysis of RNA-seq incorporating quantification uncertainty. Nature Methods 14, 687\u2013690 (2017).","DOI":"10.1038\/nmeth.4324"},{"key":"19782_CR70","doi-asserted-by":"crossref","unstructured":"Lytle, N. K. et al. A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Cell 177, 572\u2013586.e22 (2019).","DOI":"10.1016\/j.cell.2019.03.010"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19782-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19782-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19782-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:07:07Z","timestamp":1670292427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19782-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["19782"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-19782-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"assertion":[{"value":"13 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5998"}}